Document is current

Any future updates will be listed below

A MEA is a MEA is a MEA? Sequential decision making and the impact of different managed entry agreements at the manufacturer and payer level, using a case study for an oncology drug in England

Crossref DOI link: https://doi.org/10.1007/s10198-020-01228-2

Published Online: 2020-09-08

Published Print: 2021-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark